Inventiva S.a. balance sheet

At the end of fiscal 2025, Inventiva S.a. had total assets of $293m, total liabilities of $326m and shareholders' equity of −$33.5m. It held $117m in cash against $70.3m of debt: net cash of $46.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Inventiva S.a.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	65	40	129	98	93	30	100	117
Receivables	—	—	—	5	0	4	1	2
Inventory	0	0	0	0	0	0	0	—
Total current assets	82	55	163	131	114	53	115	287
Total assets	91	64	170	138	124	77	123	293
Total current liabilities	17	16	17	26	33	55	125	91
Short-term debt	0	0	0	—	—	—	—	—
Long-term debt	0	0	12	10	—	—	—	—
Total debt	0	0	12	11	47	60	—	70
Total liabilities	—	—	—	37	75	112	234	326
Shareholders' equity	71	46	136	101	49	−35	−110	−33
Net debt (negative = net cash)	−65	−40	−117	−87	−45	30	−100	−46
Shares outstanding	—	—	—	123m	126m	—	191m	193m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ANL vs IVA IMRN vs IVA IVA vs RANI

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Inventiva S.a.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inventiva S.a.